While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...
As a chief architect of Project 2025, Russell Vought has risen into the national spotlight for co-authoring the controversial ...
Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But ...